Responses
Clinical and epidemiological research
Extended report
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study
Compose a Response to This Article
Other responses
No responses have been published for this article.